App-Quantinova.ai

Coronary Artery Disease in Inflammatory Bowel Disease: a Look At the Percutaneous Coronary Intervention Outcomes

Ashish Atreja - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Impact of Genetic Predispositions, Diet, and Environment on Storage of Red Blood Cells

Steven L Spitalnik - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Quality Improvement Initiative To Prevent Deep Venous Thrombosis in Children

Neil Andrew Goldenberg - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Epidemiology of Venous Thromboembolism in Children

Edward Vincent Faustino - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Platelet Transfusions Contribute To Venous Thromboembolism Risk in Pediatric ALL Patients Receiving PEG-Aspargase

Allie Maffit - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Heparin Bridging Therapy is Associated With Post-Colorectal Polypectomy Bleeding in Patients With Interrupted Oral Anticoagulation Therapy

Yasuaki Nagami - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

The display of pro-thrombotic phenotype of mice carrying the BDNF Val66Met human polymorphism is prevented by treatment with Resveratrol

P. Amadio - Italian Society of Pharmacology (SIF) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Resveratrol

Early Use of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Primary Prophylaxis of Gastric Variceal Bleeding: Evaluation of Effectiveness and Effect on Global Liver Function

Hussein Abidali - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Human Platelets Promote the Growth and Epithelial-Mesenchymal Transition (EMT) of Colon Cancer Cells: Effects of Aspirin on Platelets From Young and Older Subjects

Dexing Fang - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Aspirin

Survey of Physician Practices in the Prevention of Venous Thromboembolism (SPOT)

Reka Thanabalan - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Fully Covered Self-Expandable Metal Stents Outperform Straight Plastic Stents in Management of Benign Anastomotic Biliary Strictures following Orthotopic Liver Transplantation

Walid M. Chalhoub - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Mofezolac

Perioperative Outcomes of Patients Undergoing Laparoscopic Cholecystectomy. the Critical Impact of Age and Operative Status

Ibrahim B. Cetindag - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

High-Risk Non-Alcoholic Steatohepatitis Liver Transplant Candidates Are at the Greatest Risk for Pre-Transplantation Portal Vein Thrombosis

Curtis K. Argo - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Splanchnic Venous Thrombosis: Is It the Strongest High Risk Feature in Pancreatic Cysts?

Saurabh S. Mukewar - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Does Prevention of Acute Clot Propagation At Diagnosis Improve Long Term Outcome of Neonatal Cerebral Sinovenous Thrombosis (NCSVT)?

Andrea V. Andrade - Pediatric Academic Societies (PAS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Multi-Center, Randomized Evaluation of the Elixir DESyne Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: 4-Year Results from the EXCELLA BD Study

Stefan Verheye - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Endoscopic Cyanoacrylate Glue Injection in Management of Gastric Variceal Hemorrhage; US Tertiary Care Center Experience

Adrian Holm - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Impact of Platelet Receptor Gene Polymorphisms on Clinical Outcomes in Patients with ST-elevation Myocardial Infarction after Percutaneous Coronary Intervention

Jia-Hui Zhang - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Effect of the ?2A-Adrenergic Receptor Genetic Variants on Platelet Reactivity and Adverse Clinical Events in Chinese Patients with Dual Antiplatelet Therapy after Percutaneous Coronary Intervention

Ying Song - Transcatheter Cardiovascular Therapeutics (TCT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients With Liver Cirrhosis - A Capsule Endoscopy Study

Shiro Oka - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

7277 Abstracts